bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Tables 1 - 2, Figure 1 from Implication of the Autologous Immune System in BCR–ABL Transcript Variations in Chronic Myelogenous Leukemia Patients Treated with Imatinib
Authors: Clapp Geoffrey D. , Lepoutre Thomas , El Cheikh Raouf , Bernard Samuel , Ruby Jérémy , Labussière-Wallet Hélène , Nicolini Franck E. , Levy Doron
Published: March 2023

Table S1:Universal parameters estimates. Table S2: Patient-specific parameter estimates. Figure S1: Comparison of the model with and without an autologous immune response
Table S3 from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Percentage inhibition of kinases by tyrosine kinase inhibitors in a KiNative in situ assay.
Table S2 from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Cellular uptake of sorafenib following transporter-directed siRNA screen.
Supplementary Figure S8 from Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis
Authors: Pettersson Filippa , del Rincon Sonia V. , Emond Audrey , Huor Bonnie , Ngan Elaine , Ng Jonathan , Dobocan Monica C. , Siegel Peter M. , Miller Wilson H.
Published: March 2023

Supplementary Figure S8. Ribavirin reduces MMP production in 66cl4 tumors in vivo.
Supplementary Figure Legends from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Legends for Supplementary Figures S1-S4.
Figure S4 from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Sorafenib-induced keratinocyte toxicity in vivo.
Figure S2 from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Identification of OAT-dependent sorafenib transport in human primary keratinocytes
FIgure S1 from Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Authors: Zimmerman Eric I. , Gibson Alice A. , Hu Shuiying , Vasilyeva Aksana , Orwick Shelley J. , Du Guoqing , Mascara Gerard P. , Ong Su Sien , Chen Taosheng , Vogel Peter , Inaba Hiroto , Maitland Michael L. , Sparreboom Alex , Baker Sharyn D.
Published: March 2023

Sorafenib and sorafenib-N-oxide accumulate in human primary keratinocytes (HEKa) via a transporter-mediated process
Supplementary Figure Legends from Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis
Authors: Pettersson Filippa , del Rincon Sonia V. , Emond Audrey , Huor Bonnie , Ngan Elaine , Ng Jonathan , Dobocan Monica C. , Siegel Peter M. , Miller Wilson H.
Published: March 2023

Legend for Supplementary Figures S1-S8.
Supplementary Figure S6 from Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner
Authors: Prabhu Varun V. , Allen Joshua E. , Dicker David T. , El-Deiry Wafik S.
Published: March 2023

Effect of DR5 and Foxo3 siRNA knockdown on ONC201/TIC10-mediated anti-CSC effect.
Supplemental Table 3 from Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression
Authors: Beheshti Afshin , Benzekry Sébastien , McDonald J. Tyson , Ma Lili , Peluso Michael , Hahnfeldt Philip , Hlatky Lynn
Published: March 2023

Supplemental Table 3. Top 5 IPA canonical pathways for each group
Supplementary Figure S5 from Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner
Authors: Prabhu Varun V. , Allen Joshua E. , Dicker David T. , El-Deiry Wafik S.
Published: March 2023

ONC201/TIC10 induces DR5 in bulk tumor cells and CSCs.
Supplementary Figure S4 from Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner
Authors: Prabhu Varun V. , Allen Joshua E. , Dicker David T. , El-Deiry Wafik S.
Published: March 2023

ONC201/TIC10-mediated CSC depletion involves inhibition of Akt, ERK and activation of Foxo3a.
Supplemental Table 1 from Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression
Authors: Beheshti Afshin , Benzekry Sébastien , McDonald J. Tyson , Ma Lili , Peluso Michael , Hahnfeldt Philip , Hlatky Lynn
Published: March 2023

Supplemental Table 1. Complete upstream regulators predicted to be activated or inhibited in the course of tumor progression
Supplementary Figure S2 from Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner
Authors: Prabhu Varun V. , Allen Joshua E. , Dicker David T. , El-Deiry Wafik S.
Published: March 2023

Post-sort validation and xenograft tumor studies.
Supplementary Tables S1-S3 from RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo–Yap Pathway
Authors: Guo Peng-Da , Lu Xing-Xing , Gan Wen-Juan , Li Xiu-Ming , He Xiao-Shun , Zhang Shen , Ji Qing-Hua , Zhou Feng , Cao Yue , Wang Jing-Ru , Li Jian-Ming , Wu Hua
Published: March 2023

Correlation of RARγ expression with patients' clinicopathological variables in 91 cases of CRC (S1); Human RARγ shRNA target sequences (S2); Primers for qPCR (S3).
Supplementary Figure Legends from Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner
Authors: Prabhu Varun V. , Allen Joshua E. , Dicker David T. , El-Deiry Wafik S.
Published: March 2023

Supplementary Figure Legends
Supplementary Materials and Methods from RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo–Yap Pathway
Authors: Guo Peng-Da , Lu Xing-Xing , Gan Wen-Juan , Li Xiu-Ming , He Xiao-Shun , Zhang Shen , Ji Qing-Hua , Zhou Feng , Cao Yue , Wang Jing-Ru , Li Jian-Ming , Wu Hua
Published: March 2023

Supplementary Materials and Methods
Supplementary Materials and Methods from PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Authors: Kolev Vihren N. , Wright Quentin G. , Vidal Christian M. , Ring Jennifer E. , Shapiro Irina M. , Ricono Jill , Weaver David T. , Padval Mahesh V. , Pachter Jonathan A. , Xu Qunli
Published: March 2023

Supplementary Materials and Methods. More detailed Materials and Methods
Supplemental Figure S2 from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
Authors: Fidel Janean , Kennedy Katie C. , Dernell William S. , Hansen Stacey , Wiss Valorie , Stroud Mark R. , Molho Joshua I. , Knoblaugh Sue E. , Meganck Jeffrey , Olson James M. , Rice Brad , Parrish-Novak Julia
Published: March 2023

ROI analysis of ex vivo and in situ tumor and normal tissues.
Supplementary Figure S3 from PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Authors: Kolev Vihren N. , Wright Quentin G. , Vidal Christian M. , Ring Jennifer E. , Shapiro Irina M. , Ricono Jill , Weaver David T. , Padval Mahesh V. , Pachter Jonathan A. , Xu Qunli
Published: March 2023

Supplementary Figure S3. Preferential targeting of Side Population (SP) CSCs in NCI-H69 cells by VS-5584.
Supplementary Figure Legends from PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Authors: Kolev Vihren N. , Wright Quentin G. , Vidal Christian M. , Ring Jennifer E. , Shapiro Irina M. , Ricono Jill , Weaver David T. , Padval Mahesh V. , Pachter Jonathan A. , Xu Qunli
Published: March 2023

Supplementary Figure Legends. Legends for Supplementary Figures S1-S5
Supplementary Movie 1 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
Authors: Chisholm Rebecca H. , Lorenzi Tommaso , Lorz Alexander , Larsen Annette K. , Almeida Luís Neves de , Escargueil Alexandre , Clairambault Jean
Published: March 2023

Supplementary Movie 1. The cell population moving through the phenotype space during one simulation of the individual-based model. In this case there are some DTPs present in the initial population (5%) together with the PC9 cells (95%). Individual cells are shown as blue circles, whereas the population mean phenotype is shown as a dotted magenta line. The movie shows that the PC9s quickly die out, allowing the DTPs to emerge, followed by the DTEPs.
Supplementary Material, Tables S1-S2 and Figures S1-S7 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
Authors: Chisholm Rebecca H. , Lorenzi Tommaso , Lorz Alexander , Larsen Annette K. , Almeida Luís Neves de , Escargueil Alexandre , Clairambault Jean
Published: March 2023

Supplementary Material, Tables S1-S2, and Figures S1-S7. Table S1. Biological considerations relating to stress-induced adaptation of cell proliferation levels with the corresponding mathematical assumptions. Table S2. Biological considerations relating to selection with the corresponding mathematical assumptions. Figure S1. Algorithm of the individual-based model and extended individual-based model with stem-like DTPs. Figure S2. The effect of the rate of genetic mutations on the trajectories of the mean phenotypic expression and the corresponding global population density as a function of time. Figure S3. The effect of the rate of phenotypic fluctuations on the trajectory of the population mean trait levels and the corresponding global population density, as a function of time, for high and low doses of cytotoxic drugs. Figure S4. The effect of the sensitivity to stress-inducing agents on the trajectory of the population mean trait levels and the corresponding global population density, as a function of time, for high and low doses of cytotoxic drugs. Figure S5. Trajectories of the phenotypic expression of six individual cells, the mean phenotypic expression of the cell population and the corresponding global population density, as a function of time. Cell distribution over the survival and proliferation potentials in the absence of drug treatment. Figure S6. Trajectories of the mean phenotypic expression, and the corresponding global population density, as a function of time, during and after drug treatment reveal the drug resensitization of DTPs and DTEPs. Figure S7. The effect of the DTP self-renewal probability on the trajectories of the mean phenotypic expression and the corresponding number of PC9s, DTPs and DTEPs as a function of time, for various drug doses.
Supplementary Figure 7 from Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth
Authors: McIntyre Alan , Hulikova Alzbeta , Ledaki Ioanna , Snell Cameron , Singleton Dean , Steers Graham , Seden Peter , Jones Dylan , Bridges Esther , Wigfield Simon , Li Ji-Liang , Russell Angela , Swietach Pawel , Harris Adrian L.
Published: March 2023

S0859 treatment does not reduce DLD-1 spheroid growth rate but does reduce the number of Ki67 positive U87 cells in spheroids.
Supplementary Figure 6 from Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth
Authors: McIntyre Alan , Hulikova Alzbeta , Ledaki Ioanna , Snell Cameron , Singleton Dean , Steers Graham , Seden Peter , Jones Dylan , Bridges Esther , Wigfield Simon , Li Ji-Liang , Russell Angela , Swietach Pawel , Harris Adrian L.
Published: March 2023

Acidic pH does not reduce 2D cell survival in combination with SLC4A4 or SLC4A9 knockdown in U87, MDA-MB-231 and LS174T.
Supplementary Figure 1 from Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth
Authors: McIntyre Alan , Hulikova Alzbeta , Ledaki Ioanna , Snell Cameron , Singleton Dean , Steers Graham , Seden Peter , Jones Dylan , Bridges Esther , Wigfield Simon , Li Ji-Liang , Russell Angela , Swietach Pawel , Harris Adrian L.
Published: March 2023

The expression of bicarbonate transporters in a panel of cell lines relative to the expression of β actin.
Supplementary Figure S1 from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis
Authors: Shen Jing , Xiao Zhangang , Wu William K.K. , Wang Maggie H. , To Ka F. , Chen Yangchao , Yang Weiqin , Li May S.M. , Shin Vivian Y. , Tong Joanna H. , Kang Wei , Zhang Lin , Li Minxing , Wang Lin , Lu Lan , Chan Ruby L.Y. , Wong Sunny H. , Yu Jun , Chan Matthew T.V. , Chan Francis K.L. , Sung Joseph J.Y. , Cheng Alfred S.L. , Cho Chi H.
Published: March 2023

Supplementary Figure S1: No effect of miR-490-3p on necrosis and apoptosis.
Supplementary Tables S1-10 from Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer
Authors: Thewes Verena , Simon Ronald , Schroeter Petra , Schlotter Magdalena , Anzeneder Tobias , Büttner Reinhard , Benes Vladimir , Sauter Guido , Burwinkel Barbara , Nicholson Robert I. , Sinn Hans-Peter , Schneeweiss Andreas , Deuschle Ulrich , Zapatka Marc , Heck Stefanie , Lichter Peter
Published: March 2023

Supplementary Tables S1-10. Supplementary Table S1: Clinico-pathological features of primary treatment-naive and relapsed tamoxifen-resistant breast carcinomas assessed by routine pathological evaluation. Supplementary Table S2: Antibodies for Western blot analyses, ChIP and immunohisto-chemistry. Supplementary Table S3: Primer sequences for qRT-PCR (5'-3'). Supplementary Table S4 : p-values. Supplementary Table S5: Top differentially expressed transcripts between MCF-7 #Wt and #TamR. Supplementary Table S6: ERalpha, ERRalpha and AIB1 target genes identified by ChIP-Seq and gene expression profiling (EP) in MCF-7 #Wt vs. # TamR cells. Supplementary Table S7: ERalpha and ERRalpha target genes identified by ChIP-Seq and gene expression profiling in MCF-7 cells. Supplemetary Table S8: Enrichment of functional categories for ERalpha and ERRalpha target genes in #TamR. Supplementary Table S9: Pairwise relationship between ERRalpha and co-variables in ERalpha-positive breast carcinomas (tumor set III, n=1041). Supplementary Table S10: Effects of co-variables on patient survival in tamoxifen-treated primary breast tumors (GSE9893) stratified to grade and PR status.
Supplementary Figure S5 from The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment
Authors: Qian Yanyan , Yuan Jupeng , Hu Huili , Yang Qifeng , Li Jisheng , Zhang Shuqian , Jiang Baichun , Shao Changshun , Gong Yaoqin
Published: March 2023

Supplementary Figure S5. p-PDK1 and PTEN in MDSCs are not affected by lack of CUL4B.
Supplementary Figure 7 from Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression
Authors: Anz David , Rapp Moritz , Eiber Stephan , Koelzer Viktor H. , Thaler Raffael , Haubner Sascha , Knott Max , Nagel Sarah , Golic Michaela , Wiedemann Gabriela M. , Bauernfeind Franz , Wurzenberger Cornelia , Hornung Veit , Scholz Christoph , Mayr Doris , Rothenfusser Simon , Endres Stefan , Bourquin Carole
Published: March 2023

Supplementary Figure 7-Efficacy of anti-tumor treatment with CpG is dependent on an CD8+ T cell response.
Supplementary Figure S1 from Novel Mechanism of Macrophage-Mediated Metastasis Revealed in a Zebrafish Model of Tumor Development
Authors: Wang Jian , Cao Ziquan , Zhang Xing-Mei , Nakamura Masaki , Sun Meili , Hartman Johan , Harris Robert A. , Sun Yuping , Cao Yihai
Published: March 2023

Supplementary Figure S1. Diagram of the multicolor zebrafish tumor model
Supplementary Figure S2 from eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells
Authors: Avdulov Svetlana , Herrera Jeremy , Smith Karen , Peterson Mark , Gomez-Garcia Jose R. , Beadnell Thomas C. , Schwertfeger Kathryn L. , Benyumov Alexey O. , Manivel J. Carlos , Li Shunan , Bielinsky Anja-Katrin , Yee Douglas , Bitterman Peter B. , Polunovsky Vitaly A.
Published: March 2023

Supplementary Fig. S2. HA-eIF4E-induced pre-malignant lesions persist in post-weaning mammary glands.
Supplementary Figure 4 from eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells
Authors: Avdulov Svetlana , Herrera Jeremy , Smith Karen , Peterson Mark , Gomez-Garcia Jose R. , Beadnell Thomas C. , Schwertfeger Kathryn L. , Benyumov Alexey O. , Manivel J. Carlos , Li Shunan , Bielinsky Anja-Katrin , Yee Douglas , Bitterman Peter B. , Polunovsky Vitaly A.
Published: March 2023

Supplementary Fig. S4. Over expressed eIF4E induces luminal subtype tumors.
Supplementary Figure S1 from Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
Authors: Lerner Robin G. , Grossauer Stefan , Kadkhodaei Banafsheh , Meyers Ian , Sidorov Maxim , Koeck Katharina , Hashizume Rintaro , Ozawa Tomoko , Phillips Joanna J. , Berger Mitchel S. , Nicolaides Theodore , James C. David , Petritsch Claudia K.
Published: March 2023

Proliferation rates and compartment overlap of CD133+ and NG2+ GBMs.
Supplementary Table S1 from MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1
Authors: Lee Jung-Hee , Park Seon-Joo , Jeong Seo-Yeon , Kim Min-Ji , Jun Semo , Lee Hyun-Seo , Chang In-Youb , Lim Sung-Chul , Yoon Sang Pil , Yong Jeongsik , You Ho Jin
Published: March 2023

Supplementary Table S1. miRNA predicted to bind the 3`UTR of the MDC1 gene by at least 4 algorithms.
Supplemental material and method from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation
Authors: Lin Dandan , Lei Lei , Liu Yonghao , Zhang Yinsheng , Hu Bo , Bao Guangming , Song Yuan , Jin Ziqi , Liu Chunliang , Mei Yu , Sandikin Dedy , Wu Yan , Zhao Lixiang , Yu Xiao , Liu Haiyan
Published: March 2023

Supplemental material and methods
Supplemental Figure S1 from Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
Authors: Ng Jessica M.Y. , Martinez Daniel , Marsh Eric D. , Zhang Zhe , Rappaport Eric , Santi Mariarita , Curran Tom
Published: March 2023

Snf5 inactivation causes neurodegeneration.
Table S1 from Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response
Authors: Bartkowiak Kai , Kwiatkowski Marcel , Buck Friedrich , Gorges Tobias M. , Nilse Lars , Assmann Volker , Andreas Antje , Müller Volkmar , Wikman Harriet , Riethdorf Sabine , Schlüter Hartmut , Pantel Klaus
Published: March 2023

Summary of the differentially expressed protein between BC-M1 and MDA-MB-468
Supplemental Table S1 from Akt–Girdin Signaling in Cancer-Associated Fibroblasts Contributes to Tumor Progression
Authors: Yamamura Yumiko , Asai Naoya , Enomoto Atsushi , Kato Takuya , Mii Shinji , Kondo Yuji , Ushida Kaori , Niimi Kaoru , Tsunoda Nobuyuki , Nagino Masato , Ichihara Shu , Furukawa Koichi , Maeda Kengo , Murohara Toyoaki , Takahashi Masahide
Published: March 2023

Clinicopathological features of 86 patients with invasive breast cancer.
Supplemental Figure 3 from Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence
Authors: Franovic Aleksandra , Elliott Kathryn C. , Seguin Laetitia , Camargo M. Fernanda , Weis Sara M. , Cheresh David A.
Published: March 2023

Requirement for integrin ligand binding function
Supplemental Figure 1 from Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence
Authors: Franovic Aleksandra , Elliott Kathryn C. , Seguin Laetitia , Camargo M. Fernanda , Weis Sara M. , Cheresh David A.
Published: March 2023

Confirmation of knockdown efficiency
Supplementary Table 1 from Copy Number Alterations in Enzyme-Coding and Cancer-Causing Genes Reprogram Tumor Metabolism
Authors: Sharma Ashwini Kumar , Eils Roland , König Rainer
Published: March 2023

Full names for cancer abbreviations used.
Supplementary Figures 1 through 5, Supplementary Figures 8 and 9, and Supplementary Figure Legends from Copy Number Alterations in Enzyme-Coding and Cancer-Causing Genes Reprogram Tumor Metabolism
Authors: Sharma Ashwini Kumar , Eils Roland , König Rainer
Published: March 2023

Fig. 1 - Description of genomic datasets, list of cancer causing genes and metabolic genes used in this study. Fig. 2 - The distribution of cancer causing genes, metabolic genes and the corresponding gene pairs in the genome. Fig. 3 - The distribution of RnpMI scores across all cancer types. Fig. 4 - Correlation between RnpMI scores and co-occurrence frequency. Fig. 5 - Gene counts after the iMetCG prioritization steps. Fig. 6 - (see additional file Supp. Fig. 6). Heatmap of prioritized cancer metabolic gene set. Fig. 7 - (see additional file Supp. Fig. 7). Heatmap of core metabolic gene set. Fig. 8 - Co-alteration of proximal cancer-metabolic gene pairs across tumor types. Fig. 9 - Tumor classification.
supplementary data from CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling
Authors: Jiang Feng , Chen Lei , Yang Ying-Cheng , Wang Xian-ming , Wang Ruo-Yu , Li Liang , Wen Wen , Chang Yan-Xin , Chen Cai-Yang , Tang Jing , Liu Gao-Mi-Yang , Huang Wen-Tao , Xu Lin , Wang Hong-Yang
Published: March 2023

supplementary materials and methods, Tables 1-3: Supplementary Table 1: Clinical Pathological Factors and CYP3A5 Expression Level Based on Immunohistochemisry in HCC Tissue Microarray. Supplementary Table 2: The summary demographics of patients participated in overall survival and tumor free survival analysis. Supplementary Table 3: Univariate Analysis of Clinical Variables Associated With Recurrence and Survival.
Supplementary Figure S8 from CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling
Authors: Jiang Feng , Chen Lei , Yang Ying-Cheng , Wang Xian-ming , Wang Ruo-Yu , Li Liang , Wen Wen , Chang Yan-Xin , Chen Cai-Yang , Tang Jing , Liu Gao-Mi-Yang , Huang Wen-Tao , Xu Lin , Wang Hong-Yang
Published: March 2023

Supplementary Figure S8: The decreased expression of CYP3A4 has no significant effect on cell proliferation, migration and invasion
Supplementary Figure S6 from CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling
Authors: Jiang Feng , Chen Lei , Yang Ying-Cheng , Wang Xian-ming , Wang Ruo-Yu , Li Liang , Wen Wen , Chang Yan-Xin , Chen Cai-Yang , Tang Jing , Liu Gao-Mi-Yang , Huang Wen-Tao , Xu Lin , Wang Hong-Yang
Published: March 2023

Supplementary Figure S6: The effect of Si-Rictor administration on CYP3A5 stable cell clines
Supplementary Table S1 from RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation
Authors: Yoldi Guillermo , Pellegrini Pasquale , Trinidad Eva M. , Cordero Alex , Gomez-Miragaya Jorge , Serra-Musach Jordi , Dougall William C. , Muñoz Purificación , Pujana Miguel-Angel , Planelles Lourdes , González-Suárez Eva
Published: March 2023

Genes differentially regulated by adjuvant and neoadjuvant RANK-Fc treatments.
Supplementary Figures S1-S8 from Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL
Authors: Chang Ting-Yu , Chen Hsin-An , Chiu Ching-Feng , Chang Yi-Wen , Kuo Tsang-Chih , Tseng Po-Chun , Wang Weu , Hung Mien-Chie , Su Jen-Liang
Published: March 2023

Dicer expression involves in paclitaxel chemosensitization (S1); Dicer expression positively correlates with better survival outcomes in breast cancer patients (S2); E1A-induced chemosensitization of paclitaxel may through both Dicer- and E2Fs-mediated mechanisms (S3); AXL expression increases paclitaxel resistance of breast cancer cells, and positively correlates with invasive breast cancer carcinoma (S4); Dicer suppresses AXL expression and enhances doxorubicin, fluorouracil and cisplatin sensitization in MCF7 cells (S5); The mRNA and protein stability of Dicer in MDA-MB-231/vector and MDA-MB-231/E1A cells (S6); The association of C/EBPα expression in advanced breast cancer (S7); C/EBPα and MAPK14 expression positively correlates with better survival outcomes in breast cancer patients (S8).
Supplemental Figure Legends from Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis
Authors: Vu Ngoc T. , Park Margaret A. , Shultz Michael D. , Bulut Gamze B. , Ladd Amy C. , Chalfant Charles E.
Published: March 2023

Supplemental Figure Legends for Supplemental Figures 1 through 12.
Supplementary Figures S1-8 from Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo
Authors: Yue Peibin , Lopez-Tapia Francisco , Paladino David , Li Yifei , Chen Chih-Hong , Hilliard Tyvette , Chen Yuan , Tius Marcus A. , Turkson James
Published: March 2023

Supplementary Figures S1-8. Fig. S1: EMSA analysis of Stat3 DNA-binding activity in vitro showing the effect of BP-1-102. Fig. S2: Effects of SH5-07, SH4-54 or BP-1-102 on Stat3 tyrosine and serine phosphorylation in tumor cells and on Stat3 DNA-binding activity in vitro. Fig. S3. Immunoblotting analysis for the effects of SH4-54 and SH5-07 on the induction of Stat3-independent signal transduction events. Fig. S4. Immunoblotting analysis for the effects of SH5-07 on EGF-induced phosphorylation of the EGF receptor and Stat3. Fig. S5. Nuclear magnetic resonance analysis of SH4-54 or Stat3 in solution alone or with N-Ethylmaleimide (NEM). Fig. S6. Immunoblotting analysis of the total Stat3 and phospho-TyrStat3 levels across diverse cell lines. Fig. S7. Transformation and migration studies in vitro of MDA-MB-231, U251MG or DU145 cells and the effects of SH5-07. Fig. S8. Body weights, blood cell counts, and the gross anatomical presentation of the organs of tumor-bearing mice and the effects of SH5-07 or SH4-54.
Supplementary Movie S1C from Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function
Authors: Park Min Chul , Jeong Hyobin , Son Sung Hwa , Kim YounHa , Han Daeyoung , Goughnour Peter C. , Kang Taehee , Kwon Nam Hoon , Moon Hyo Eun , Paek Sun Ha , Hwang Daehee , Seol Ho Jun , Nam Do-Hyun , Kim Sunghoon
Published: March 2023

Spheroid formation of cancer cells - A549 (A)
Supplementary Figure Legends from Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function
Authors: Park Min Chul , Jeong Hyobin , Son Sung Hwa , Kim YounHa , Han Daeyoung , Goughnour Peter C. , Kang Taehee , Kwon Nam Hoon , Moon Hyo Eun , Paek Sun Ha , Hwang Daehee , Seol Ho Jun , Nam Do-Hyun , Kim Sunghoon
Published: March 2023

Supplementary Figure Legends
Supplementary figure 3 from SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression
Authors: Tanaka Masamitsu , Shimamura Shintaro , Kuriyama Sei , Maeda Daichi , Goto Akiteru , Aiba Namiko
Published: March 2023

Supplementary data of Figure 6
Supplementary figure 2 from SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression
Authors: Tanaka Masamitsu , Shimamura Shintaro , Kuriyama Sei , Maeda Daichi , Goto Akiteru , Aiba Namiko
Published: March 2023

Immunofluorescence staining of SKAP2 and gel invasion assay
Supplementary Table S5 from Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression
Authors: Bisikirska Brygida , Bansal Mukesh , Shen Yao , Teruya-Feldstein Julie , Chaganti Raju , Califano Andrea
Published: March 2023

Excess-over-BLISS (EOB) scores for drug combinations
Supplementary figure 1 from SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression
Authors: Tanaka Masamitsu , Shimamura Shintaro , Kuriyama Sei , Maeda Daichi , Goto Akiteru , Aiba Namiko
Published: March 2023

Immunohistochemistry and RT-PCR
Supplementary Methods from Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression
Authors: Bisikirska Brygida , Bansal Mukesh , Shen Yao , Teruya-Feldstein Julie , Chaganti Raju , Califano Andrea
Published: March 2023

Supplementary Methods
Supplementary Figure Legends from Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression
Authors: Bisikirska Brygida , Bansal Mukesh , Shen Yao , Teruya-Feldstein Julie , Chaganti Raju , Califano Andrea
Published: March 2023

Supplementary figure legends for S1-S4
Supplemental Figure Legends from Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer
Authors: Cook Katherine L. , Soto-Pantoja David R. , Clarke Pamela A.G. , Cruz M. Idalia , Zwart Alan , Wärri Anni , Hilakivi-Clarke Leena , Roberts David D. , Clarke Robert
Published: March 2023

Legends descriptions and supplemental experimental descriptions
Supplemental Figure 4 from Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer
Authors: Cook Katherine L. , Soto-Pantoja David R. , Clarke Pamela A.G. , Cruz M. Idalia , Zwart Alan , Wärri Anni , Hilakivi-Clarke Leena , Roberts David D. , Clarke Robert
Published: March 2023

A. LCC9 breast cancer cells were transfected with control siRNA, GRP78 siRNA, control pcDNA, or GRP78 cDNA for 72 hours and CD47, calreticulin, and HMGB1 protein expression measured by Western blot hybridization. B. LCC9 xenografts from control mice or mice treated with TAM, GRP78M, or GRP78M+TAM were stained for CD47 and visualized at 20X. n=6; *p<0.05.
Supplementary Table S5 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

Multi variate analysis of factors associated with overall survival.
Supplementary Tables from Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer
Authors: Merino Vanessa F. , Nguyen Nguyen , Jin Kideok , Sadik Helen , Cho Soonweng , Korangath Preethi , Han Liangfeng , Foster Yolanda M.N. , Zhou Xian C. , Zhang Zhe , Connolly Roisin M. , Stearns Vered , Ali Syed Z. , Adams Christina , Chen Qian , Pan Duojia , Huso David L. , Ordentlich Peter , Brodie Angela , Sukumar Saraswati
Published: March 2023

Supplemental Tables: Supplementary Table S1A. Estimated tumor volume of MDA-MB-231 xenografts treated with entinostat, ATRA, and doxorubicin as single and combined therapies. Supplementary Table S1B. Comparison of the estimated tumor volume of MDA-MB-231 xenografts treated with entinostat, ATRA, and doxorubicin as single and combined therapies. Supplementary Table S2A. Estimated tumor volume of SUM-159 xenografts treated with entinostat, ATRA, and doxorubicin as single and combined therapy. Supplementary Table S2B. Comparison of the estimated tumor volume of SUM-159 xenografts treated with entinostat, ATRA, and doxorubicin as single and combined therapy. Supplementary Table S3A. Estimated tumor volume of MDA-MB-231 xenografts treated with entinostat, ATRA, and carboplatin as single and combined therapy. Supplementary Table S3B. Comparison of the estimated tumor volume of MDA-MB-231 xenografts treated with entinostat, ATRA, and carboplatin as single and combined therapies. Supplementary Table S4A. Estimated tumor volume of SUM-159 xenografts treated with entinostat, ATRA, and carboplatin as single and combined therapy. Supplementary Table S4B. Comparison of the estimated tumor volume of SUM-159 xenografts treated with entinostat, ATRA, and carboplatin as single and combined therapy. Supplementary Table S5. Necrosis scores in mouse xenografts. Supplementary Table S6. EAD treatment shows reduced tumor incidence at limiting dilution. Supplementary Table S7. Characteristics of primary patient samples.
Supplemental Figures from Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer
Authors: Merino Vanessa F. , Nguyen Nguyen , Jin Kideok , Sadik Helen , Cho Soonweng , Korangath Preethi , Han Liangfeng , Foster Yolanda M.N. , Zhou Xian C. , Zhang Zhe , Connolly Roisin M. , Stearns Vered , Ali Syed Z. , Adams Christina , Chen Qian , Pan Duojia , Huso David L. , Ordentlich Peter , Brodie Angela , Sukumar Saraswati
Published: March 2023

Supplemental Figures: Supplementary Figure 1 - Paclitaxel or carboplatin is less effective than doxorubicin in combination with entinostat and ATRA on induction of cell death. Supplementary Figure 2 - Paclitaxel or carboplatin in the combination is less effective than doxorubicin on induction of RAR-β expression; depletion of RAR-β decreases sensitivity to EAD; and transcriptional regulation of RAR-β by TopoII-β Supplementary Figure 3 - EAD decreases the number of CD44+/CD24-/Epcam+ cells and induces expression of differentiation markers Supplementary Figure 4 - EAD potentiates differentiation in vivo. Supplementary Figure 5 - ELF-3 is increased in differentiated stem cell and mediates the entinostat-differentiation effect. Supplementary Figure 6 - EAD targets metastatic samples.
Supplementary Table S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

Correlation between different platforms.
Supplemental Figure Legends from Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer
Authors: Merino Vanessa F. , Nguyen Nguyen , Jin Kideok , Sadik Helen , Cho Soonweng , Korangath Preethi , Han Liangfeng , Foster Yolanda M.N. , Zhou Xian C. , Zhang Zhe , Connolly Roisin M. , Stearns Vered , Ali Syed Z. , Adams Christina , Chen Qian , Pan Duojia , Huso David L. , Ordentlich Peter , Brodie Angela , Sukumar Saraswati
Published: March 2023

Supplemental Figure S1 Legend Supplemental Figure S2 Legend Supplemental Figure S3 Legend Supplemental Figure S4 Legend Supplemental Figure S5 Legend Supplemental Figure S6 Legend
Supplementary Figure S9 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

A non-significant tendency towards increased survival was observed in tumors with high expression of either FMO4 (A) or OSBPL3 (B) of patients receiving bevacizumab in the TCGA dataset.
Supplemental Table S1 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: March 2023

TaqMan gene expression assays used for qPCR.
Supplementary Figure S7 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

Survival analysis of molecular pathways that are differentially expressed between IGS-18 and all other molecular subtypes.
Supplementary Figure S5 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: March 2023

Mutations segregate in distinct molecular subtypes.
Supplemental Figure S4 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: March 2023

MACROPHAGE DEPLETION BY ANTI-CSF1.
Supplemental Figure S3 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: March 2023

INCREASED ACCUMULATION OF LYMPHOCYTES IN SEMA3A TUMORS.
Supplemental Figure S2 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: March 2023

SEMA3AS EFFECT ON MONOCYTES AND MACROPHAGES.
Supplementary Materials and Methods from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: March 2023

Supplementary Materials and Methods. Description of additional methods and procedures used in the study.
Supplementary Legends for Supplementary Figures S1-S4 from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: March 2023

Supplementary Legends for Supplementary Figures S1-S4.
Supplementary Figure S4 from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: March 2023

Supplementary Figure S4. Histological evaluation of the vascular phenotype of U-87 MG, RG2 and MDA-MB-231 tumors.
Supplementary Figure S3 from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: March 2023

Supplementary Figure S3. Representative Luxol Fast Blue staining for myelin fibres within intracranial U-87 MG, RG2 and MDA-MB-231 tumors.
Supplementary Figure S1 from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: March 2023

Supplementary Figure S1. Schematic of the MR elastography platform used in this study.
Supplementary data from Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity
Authors: Brentville Victoria A. , Metheringham Rachael L. , Gunn Barbara , Symonds Peter , Daniels Ian , Gijon Mohamed , Cook Katherine , Xue Wei , Durrant Lindy G.
Published: March 2023

Supplementary figure 1-3 Supplementary tables 1 and 2 Supplementary data showing responses induced in mice from double and triple citrullinated vimentin aa28-49 peptides, murine aa415-433 peptide and evidence responses are not CD8 mediated as well as vimentin peptide sequences and cytokine data from human patient.
Supplementary Table S1 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: March 2023

Mouse diet calorie and nutrient content.
Supplementary Table S2 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: March 2023

Connectivity Map results.
Supplementary Figure S5 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: March 2023

ABCA1 drives metastasis in vivo.
Supplementary Figure S2 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: March 2023

Relative GUCY2C expression in proximal (PC) and distal (DC) colons of mice on lean or high fat (HF) diets.
Supplementary Figure S2 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: March 2023

Drug treatment alters metastatic capacity.
Supplementary Methods and References from Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression
Authors: Picon-Ruiz Manuel , Pan Chendong , Drews-Elger Katherine , Jang Kibeom , Besser Alexandra H. , Zhao Dekuang , Morata-Tarifa Cynthia , Kim Minsoon , Ince Tan A. , Azzam Diana J. , Wander Seth A. , Wang Bin , Ergonul Burcu , Datar Ram H. , Cote Richard J. , Howard Guy A. , El-Ashry Dorraya , Torné-Poyatos Pablo , Marchal Juan A. , Slingerland Joyce M.
Published: March 2023

Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Table S2 from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
Authors: Rao Shreyas S. , Bushnell Grace G. , Azarin Samira M. , Spicer Graham , Aguado Brian A. , Stoehr Jenna R. , Jiang Eric J. , Backman Vadim , Shea Lonnie D. , Jeruss Jacqueline S.
Published: March 2023

Sacrifice end points observed in the post-surgical model in the mock and scaffold groups with resection performed at day 10 without Gr-1 depletion.
Supplementary Figures from Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix–Directed Spheroid Formation
Authors: Kasagi Yuta , Harada Yui , Morodomi Yosuke , Iwai Toshiki , Saito Satoru , Yoshida Kumi , Oki Eiji , Saeki Hiroshi , Ohgaki Kippei , Sugiyama Masahiko , Onimaru Mitsuho , Maehara Yoshihiko , Yonemitsu Yoshikazu
Published: March 2023

Supplementary Figure S1-7
Supplementary Table S2 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: March 2023

A list of genes upregulated by JMJD3 in A375-LM3 cells.